Overview
Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore the impact of early-life antibiotic exposure on the human microbiome and its potential link to obesity in adulthood through this 27-minute conference talk by the American Society for Microbiology. Delve into the variables affecting infant microbiome development, including birth method and antibiotic use, and examine their long-term effects on metabolism and body composition using mouse models. Learn from experts Laura Cox of NYU Langone Medical Center and Elizabeth Costello of Stanford University School of Medicine as they discuss research findings, antibiotic therapy implications, microbiome recovery, and the differences between laboratory animals and human infants. Gain insights into ongoing studies, the potential of probiotics and prebiotics, and their relationship to obesity prevention.
Syllabus
Introduction
Research Background
Obesity
Longterm therapy with antibiotics
Does the antibiotic matter
Antibiotics and the microbiome
Rebounding from antibiotic treatment
Differences in studying laboratory animals
Mice becoming obese
Human infants
Expanding the study
Probiotics and prebiotics
Probiotics and Obesity
Question from the audience
Biggest surprise
Conclusion
Taught by
American Society for Microbiology